Методы определения давности тромбоза

Актуальность: Венозные тромбоэмболические осложнения – грозное состояние с высоким риском летального исхода, нередко встречается в практике врача любой специальности. Своевременная диагностика и грамотная тактика ведения пациентов с тромбоэмболическими осложнениями являются ключевыми в благоприятном исходе заболевания. Актуальными проблемами для науки являются поиск и разработка диагностических подходов с целью получения полной характеристики тромботического события. Определение давности тромбоза – это один из таких значимых критериев, четкое понимание которого позволит выбрать успешную стратегию лечения пациентов с подобными осложнениями.
Цель исследования: На сегодняшний день оценка возраста тромба строится в основном на анамнестических данных больного, которые не всегда отражают истинную картину, а также визуализирующих методиках, опирающихся на косвенные признаки. Поэтому неэффективность терапии описываемых состояний в некоторых случаях можно объяснить недооценкой возраста тромба. Развитие научных исследований в этом направлении представляется перспективным и способным привести к улучшению результатов лечения пациентов, страдающих венозными тромбоэмболическими осложнениями. В представленной обзорной статье авторы проанализировали имеющиеся в литературе методы определения давности тромбоза.

1. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–593. PMID: 9521222. https://doi.org/10.1001/archinte.158.6.585

2. Spencer FA, Goldberg RJ, Lessard D, et al. Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism Study. Circ Cardiovasc Qual Outcomes. 2010;3(4):390–394. PMID: 20606125. PMCID: PMC3248812. https://doi.org/10.1161/circoutcomes.110.937441

3. White RH, Zhou H, Murin S, et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost. 2005;93(2):298–305. PMID: 15711746. https://doi.org/10.1160/th04-08-0506

4. Beckman MG, Hooper WC, Critchley SE, et al. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38:S495–501. PMID: 20331949. https://doi.org/10.1016/j.amepre.2009.12.017

5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. PMID: 30620402. https://doi.org/10.3322/caac.21551

6. Dobesh PP. Economic burden of venous thromboembolism in hospitalized patients. Pharmacotherapy. 2009;29(8):943–953. PMID: 19637948. https://doi.org/10.1592/phco.29.8.943

7. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4–8. PMID: 12814979. https://doi.org/10.1161/01.cir.0000078468.11849.66

8. Nitta D, Mitani H, Ishimura R, et al. Deep vein thrombosis risk stratification. Int Heart J. 2013;54(3):166–170. PMID: 23774241. https://doi.org/10.1536/ihj.54.166

9. Spyropoulos AC, Hurley JS, Ciesla GN, et al. Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin. Chest. 2002;122(1):108–114. PMID: 12114345. https://doi.org/10.1378/chest.122.1.108

10. Monreal M, Agnelli G, Chuang LH, et al. Deep Vein Thrombosis in Europe-Health-Related Quality of Life and Mortality. Clin Appl Thromb Hemost. 2019;25:1076029619883946. PMID: 31840534. PMCID: PMC7027084. https://doi.org/10.1177/1076029619883946

11. Yusof NNM, McCann A, Little PJ, et al. Non-invasive imaging techniques for the differentiation of acute and chronic thrombosis. Thromb Res. 2019;177:161–171. PMID: 30921535. https://doi.org/10.1016/j.thromres.2019.03.009

12. Hess S, Madsen PH, Basu S, et al. Potential role of FDG PET/CT imaging for assessing venous thromboembolic disorders. Clin Nucl Med. 2012;37(12):1170–1172. PMID: 23154475. https://doi.org/10.1097/rlu.0b013e318279bf73

13. Wilbur J, Shian B. Diagnosis of deep venous thrombosis and pulmonary embolism. Am Fam Physician. 2012;86(10):913–919. PMID: 23157144.

14. Wheeler HB, Anderson FA Jr. Diagnostic methods for deep vein thrombosis. Haemostasis. 1995;25(1–2):6–26. PMID: 7896224. https://doi.org/10.1159/000217140

15. Aggarwal A, Bhalotra AR, Suresh V, et al. Assessing the age of deep vein thrombus: A need for future perioperative medicine and anesthesia. Anesth Essays Res. 2016;10(1):1–2. PMID: 26957680. PMCID: PMC4767089. https://doi.org/10.4103/0259-1162.167803

16. Screaton NJ, Gillard JH, Berman LH, et al. Duplicated superficial femoral veins: a source of error in the sonographic investigation of deep vein thrombosis. Radiology. 1998;206(2):397–401. PMID: 9457192. https://doi.org/10.1148/radiology.206.2.9457192

17. Cronan JJ. Venous thromboembolic disease: the role of US. Radiology. 1993;186(3):619–630. PMID: 8430164. https://doi.org/10.1148/radiology.186.3.8430164

18. Schmitt C, Montagnon E, Hadj Henni A, et al. Shear Wave Induced Resonance Elastography of Venous Thrombi: A Proof-of-Concept. IEEE Transactions on Medical Imaging. 2013;32(3):565–577. PMID: 23232414. https://doi.org/10.1109/tmi.2012.2231093

19. Yi X, Wei X, Wang Y, et al. Role of real-time elastography in assessing the stage of thrombus. Int Angiol. 2017;36(1):59–63. PMID: 27070908. https://doi.org/10.23736/s0392-9590.16.03610-5

20. Mumoli N, Mastroiacovo D, Giorgi-Pierfranceschi M, et al. Ultrasound elastography is useful to distinguish acute and chronic deep vein thrombosis. J Thromb Haemost. 2018;16(12):2482–2491. PMID: 30225971. https://doi.org/10.1111/jth.14297

21. Aslan A, Barutca H, Ayaz E, et al. Is real-time elastography helpful to differentiate acute from subacute deep venous thrombosis? A preliminary study. J Clin Ultrasound. 2018;46(2):116–121. PMID: 28940429. https://doi.org/10.1002/jcu.22522

22. Ненарочнов С.В., Новикова Я.В., Куликов В.Г. и др. Метод оценки эмболоопастности венозных тромбов с использованием соноэластографии. Фундаментальные исследования. 2011;10(2):329–332.

23. Paluch Ł, Nawrocka-Laskus E, Dąbrowska A, et al. Ultrasound Elastography for Determination of the Age of Venous Thrombi. Evaluation of Thrombus Evolution in Patients After Sclerotherapy. Pol J Radiol. 2017;82:88–91. PMID: 28289480. PMCID: PMC5321172. https://doi.org/10.12659/pjr.899517

24. Fang J, Chen CK, Peng JY, et al. Changes in backscattered ultrasonic envelope statistics as a function of thrombus age: an in vitro study. Ultrasound Med Biol. 2015;41(2):498–508. PMID: 25542488. https://doi.org/10.1016/j.ultrasmedbio.2014.09.024

25. Гольдина И.М. Новые подходы к ультразвуковой диагностике эмбологенного венозного венозного тромбоза. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2013;(4):20–25.

26. Drescher R, Freesmeyer M. PET angiography: Application of early dynamic PET/CT to the evaluation of arteries. AJR Am J Roentgenol. 2013;201(4):908–911. PMID: 24059383. https://doi.org/10.2214/ajr.12.10438

27. Nazaroğlu H, Ozmen CA, Akay HO, et al. 64-MDCT pulmonary angiography and CT venography in the diagnosis of thromboembolic disease. AJR Am J Roentgenol. 2009;192(3):654–661. PMID: 19234261. https://doi.org/10.2214/ajr.07.3939

28. van Dam LF, Dronkers CEA, Gautam G, et al. Detection of upper extremity deep vein thrombosis by magnetic resonance noncontrast thrombus imaging. J Thromb Haemost. 2021;19(8):1973–1980. PMID: 34018662. PMCID: PMC8361740. https://doi.org/10.1111/jth.15394

29. Вихрова Н.Б., Долгушин Б.И., Панов В.О. и др. Лучевые методы диагностики в определении структуры опухолевого тромбоза в нижней полой вене при раке почки. Онкоурология. 2015;11(3):40–45. http://doi.org/10.17650/1726-9776-2015-11-3-40-45

30. Saha P, Humphries J, Modarai B, et al. Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. Smith Arterioscler Thromb Vasc Biol. 2011;31(3):506–112. PMID: 21325673. PMCID: PMC3079895. https://doi.org/10.1161/atvbaha.110.213405

31. Andia ME, Saha P, Jenkins J, et al. Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis. Arterioscler Thromb Vasc Biol. 2014;34(6):1193–1198. PMID: 24723557. PMCID: PMC4195984. https://doi.org/10.1161/atvbaha.113.302931

32. Corti R, Osende J, Fayad ZA, et al. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol. 2002;39(8):1366–1373. PMID: 11955857. https://doi.org/10.1016/s0735-1097(02)01754-0

33. Drescher R, Freesmeyer M. PET angiography: Application of early dynamic PET/CT to the evaluation of arteries. AJR Am J Roentgenol. 2013;201(4):908–911. PMID: 24059383. https://doi.org/10.2214/ajr.12.10438

34. Rondina MT, Lam UT, Pendleton RC, et al. (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis. Clin Nucl Med. 2012;37(12):1139–1145. PMID: 23154470. PMCID: PMC3564643. https://doi.org/10.1097/rlu.0b013e3182638934

35. Housmand S, Salavati A, Hess S, et al. The role of molecular imaging in diagnosis of deep vein thrombosis. Am J Nucl Med Mol Imaging. 2014;4(5):406–25. PMID: 25143860. PMCID: PMC4138136.

36. Taillefer R. Radiolabeled peptides in the detection of deep venous thrombosis. Semin Nucl Med. 2001;31(2):102–123. PMID: 11330782. https://doi.org/10.1053/snuc.2001.21268

37. Березовский Д.П., Грибенников С.Н., Додохова М.А. Тромбозы в судебной медицине. Медицинский вестник Северного Кавказа. 2011;1(21):79–82.

38. Митрофанова Л.Б., Аминева Х.К. Макроскопический и органометрический анализ сердца в патологии: пособие для врачей под ред. Ковальского Г.Б. Санкт-Петербург: ГПАБ; 1998:60.

39. Fineschi V, Turillazzi E, Neri M, et al. Histological age determination of venous thrombosis: a neglected forensic task in fatal pulmonary thrombo-embolism. Forensic Sci Int. 2009;186(1–3):22–28. PMID: 19203853. https://doi.org/10.1016/j.forsciint.2009.01.006

40. Fuijkschot WW, Groothuizen WE, Appelman Y, et al. Inflammatory cell content of coronary thrombi is dependent on thrombus age in patients with ST-elevation myocardial infarction. J Cardiol. 2017;69(1):394–400. PMID: 27836374. https://doi.org/10.1016/j.jjcc.2016.10.003

41. Furukoji E, Gi T, Yamashita A, et al. CD163 macrophage and erythrocyte contents in aspirated deep vein thrombus are associated with the time after onset: a pilot study. Thromb J. 2016;14:46. PMID: 27895532. PMCID: PMC5120412. https://doi.org/10.1186/s12959-016-0122-0

42. Nosaka M, Ishida Y, Kuninaka Y, et al. Immunohistochemical detection of uPA, tPA, and PAI-1 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation. Int J Legal Med. 2012;126(3):421–425. PMID: 22361951. https://doi.org/10.1007/s00414-012-0680-z

43. Nosaka M, Ishida Y, Kimura A, et al. Immunohistochemical detection of intrathrombotic macrophage-derived cytokines and its application to thrombus age estimation in murine deep vein thrombosis model. Int J Legal Med. 2013;127(5):937–942. https://doi.org/10.1007/s00414-013-0873-0

44. Nosaka M, Ishida Y, Kimura A, et al. Immunohistochemical detection of intrathrombotic IL-6 and its application to thrombus age estimation. Int J Legal Med. 2015;129(5):1021–1025. PMID: 25616628. https://doi.org/10.1007/s00414-015-1147-9

45. Nosaka M, Ishida Y, Kimura A, et al. Immunohistochemical detection of intrathrombotic fibrocytes and its application to thrombus age estimation in murine deep vein thrombosis model. Int J Legal Med. 2017;131(1):179–183. PMID: 27757576. https://doi.org/10.1007/s00414-016-1465-6

46. Nosaka M, Ishida Y, Kimura A, et al. Detection of intrathrombotic endothelial progenitor cells and its application to thrombus age estimation in a murine deep vein thrombosis model. Int J Legal Med. 2017;131(6):1633–1638. PMID: 28828624. https://doi.org/10.1007/s00414-017-1668-5

47. Nosaka M, Ishida Y, Kimura A, et al. Immunohistochemical detection of MMP-2 and MMP-9 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation. Int J Legal Med. 2010;124(5):439–444. PMID: 20623133. https://doi.org/10.1007/s00414-010-0484-y

48. Nosaka M, Ishida Y, Kimura A, et al. Time-dependent appearance of intrathrombus neutrophils and macrophages in a stasisinduced deep vein thrombosis model and its application to thrombus age determination. Int J Legal Med. 2009;123(3):235–240. PMID: 19194719. https://doi.org/10.1007/s00414-009-0324-0

49. Stein-Merlob AF, Kessinger CW, Erdem SS, et al. Blood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study. Theranostics. 2015;5(12):1317–1327. PMID: 26516370. PMCID: PMC4615735. https://doi.org/10.7150/thno.12494

50. Maffeis V, Nicolè L, Rago C, et al. Histological criteria for age determination of fatal venous thromboembolism. Int J Legal Med. 2018;132(3):775–780. PMID: 29052040. https://doi.org/10.1007/s00414-017-1705-4